Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Abeona Therapeutics (ABEO) over the last 11 years, with Q3 2025 value amounting to 0.09.

  • Abeona Therapeutics' Debt Ratio fell 4473.65% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year decrease of 4473.65%. This contributed to the annual value of 0.17 for FY2024, which is N/A changed from last year.
  • Per Abeona Therapeutics' latest filing, its Debt Ratio stood at 0.09 for Q3 2025, which was down 4473.65% from 0.08 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Debt Ratio high stood at 0.26 for Q2 2021, and its period low was 0.06 during Q4 2022.
  • Over the past 4 years, Abeona Therapeutics' median Debt Ratio value was 0.17 (recorded in 2024), while the average stood at 0.17.
  • The largest annual percentage gain for Abeona Therapeutics' Debt Ratio in the last 5 years was 5088.34% (2021), contrasted with its biggest fall of 5140.19% (2021).
  • Over the past 4 years, Abeona Therapeutics' Debt Ratio (Quarter) stood at 0.11 in 2021, then crashed by 38.77% to 0.06 in 2022, then skyrocketed by 168.52% to 0.17 in 2024, then tumbled by 50.9% to 0.09 in 2025.
  • Its last three reported values are 0.09 in Q3 2025, 0.08 for Q2 2025, and 0.19 during Q1 2025.